Entrar/Registro  
HOME SPANISH
 
Revista Mexicana de Neurociencia
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista Mexicana de Neurociencia >Year 2018, Issue 4


Grisold W, Grisold S
Placebo, nocebo and no treatment
Rev Mex Neuroci 2018; 19 (4)

Language: Inglés
References: 48
Page: 4-15
PDF: 306.26 Kb.


Full text




ABSTRACT

The far-reaching meaning of placebo and nocebo are often undervalued or ignored in clinical practice. Presently the term placebo is either used: (1) in the context of randomized controlled trials, (2) to describe a sham treatment in various nuances, (3) to describe effects often attributed to healers.This diverges from “no treatment” which has entirely different implications. Even less accepted is the term nocebo, which literally means “will harm”. As placebo this term can be ambiguous and can appear in many concealed ways. Research in the past years has been based on experiments and elaborated studies and on imaging studies. This both placebo and nocebo also have an empirical and scientific background. Also, ethical aspects concern placebo and nocebo issues, in particular in regard to changing relations of the physician- patient relationship, which affects both terms. Based on this knowledge, increasingly physicians and patients are aware of these phenomena, and it will be important to raise awareness not only in physicians, but also the health care personal involved in the treatment of patients.


Key words: placebo, nocebo, no treatment, mechanisms, ethics.


REFERENCIAS

  1. Thompson WG, The placebo effect and health. Book: Prometheus Book. NY, 2003.

  2. Kradin, RL., The Placebo Response and the Power of Unconscious Healing Book: Routledge. Taylor and Francis group. New York London: p. 1-292. 2008.

  3. Brown, WA., The placebo effect in clinical practice. Oxford university Press. 2013.

  4. Howick J, C.F., Tsakok M, Watson R, et al. Are Treatments More Effective than Placebos? A Systematic Review and Meta-Analysis. PLOS ONE | www.plosone.org 1 May 2013 | Volume 8 | Issue 5 | e62599, 2013.

  5. Shapiro AK, Shapiro MD., The Powerful Placebo: From Ancient Priest to Modern Physician. The John Hopkins University Press, 1997.

  6. Woldeamanuel, Y.W., Andreou AP, Cowan RP. Prevalence of migraine headache and its weight on neurological burden in Africa: a 43-year systematic review and meta-analysis of community-based studies. J Neurol Sci. 2014. 342 (1-2): p. 1-15.

  7. Benedetti, F, Placebo and the new physiology of the doctor-patient relationship. Physiol Rev. 2013. 93 (3): p. 1207-46.

  8. Abdulraheem, S. and L. Bondemark, Hawthorne effect reporting in orthodontic randomized controlled trials: truth or myth? Blessing or curse? Eur J Orthod. 2017.

  9. Cuerda-Galindo, Sierra Valenti X, Gonzales Kopes E et al. Syphilis and human experimentation from World War II to the present: a historical perspective and reflections on ethics. Actas Dermosifiliogr. 2014. 105 (9): p. 847-53.

  10. Lucas, V. and S. Booth, The importance of placebo effects in enhancing palliative care interventions. BMJ Support Palliat Care. 2014. 4 (2): p. 212-216.

  11. Hall, K.T., J. Loscalzo, and T.J. Kaptchuk, Genetics and the placebo effect: the placebome. Trends Mol Med. 2015. 21(5): p. 285-94.

  12. Vase, L., I. Skyt, and K.T. Hall, Placebo, nocebo, and neuropathic pain. Pain. 2016. 157 Suppl 1: p. S98-105.

  13. Benedetti, F.Enck P, Frisaldi L. Placebo. Handbook of Experimental Pharmacology 225. Springer. ISBN 978-3-662-44519-8 (eBook), 2014.

  14. Colagiuri, B., Schenk LA; Kessler MD, et al. The placebo effect: From concepts to genes. Neuroscience. 2015. 307: p. 171-190.

  15. Benedetti, F. and Dogue S, Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials. PLoS One. 2015. 10 (11): p. e0140967.

  16. Benedetti F, Carlino E, Pollo A. How Placebos Change the Patient’s Brain. Neuropsychopharmacology REVIEWS. (2011) 36, 339–354, 2011.

  17. Finnissa DG, T.J.K., Miller F, Benedettid F, Placebo Effects: Biological, Clinical and Ethical Advances. Lancet. 2010 February 20; 375 (9715): 686–695. doi:10.1016/S0140-6736 (09)61706-2., 2010.

  18. Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A metaregression of double-blind, randomized clinical trials in MDD. Eur. Neuropsychopharmacol. 19 (2009) 34–40, 2009.

  19. Colloca L1, Miller FG. How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond B Biol Sci. 2011; 366:1859-1869

  20. Linde K, C.F. ,Alscher A, Schneider A, Verwendung komplementärer Therapien und Einsatz von Placebos durch niedergelassene Ärzte in Deutschland. „ Use of Complementary Therapies and Placebos by German Physicians Working in Private Practice.“ Deutscher Ärzte-Verlag | ZFA | Z Allg Med | 2015; 91 (6), 2015.

  21. Moerman, D.E., Meaning, Medicine, and the “Placebo Effect”. Cambridge University press Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, São Paulo, 2002.

  22. Sheldon, R. and M. Opie-Moran, The Placebo Effect in Cardiology: Understanding and Using It. Can J Cardiol. 2017. 33 (12): p. 1,535-1,542.

  23. Kraft-Todd, G.T.,Reienero DA, Kelley JM et al. Empathic nonverbal behavior increases ratings of both warmth and competence in a medical context. PLoS One. 2017. 12 (5): p. e0177758.

  24. Braga-Simoes, J., P.S. Costa, and J. Yaphe, Placebo prescription and empathy of the physician: A crosssectional study. Eur J Gen Pract. 2017. 23 (1): p. 98-104.

  25. Jarrad R , Hammad S Shawashi T. Compassion fatigue and substance use among nurses. Ann Gen Psychiatry. 2018. 17: p. 13.

  26. Chisholm, C.,Heybourn R, Short T et al . Reflections about “burn-out”. Acad Emerg Med. 2009. 16 (6): p. 567-71.

  27. Green, G., A burnt out case. 1960. (Book)

  28. Sinclair, S, Beamer S, Hack TF. Sympathy, empathy, and compassion: A grounded theory study of palliative care patients’ understandings, experiences, and preferences. Palliat Med. 2017. 31 (5): p. 437-447.

  29. Reddy, N.K.A., Santosh., Ethics, Integrity and Aptitude. (https://books.google.com/books?id=YLly CgAAQBAJ&pg=PA146). McGraw-Hill Education. p. 146. ISBN 978-93-5134-236-6., 2014.

  30. Bostick NA, Sade R. Levine R et al, Placebo Use in Clinical Practice:Report of the American Medical Association Council on Ethical and Judicial Affairs. The Journal of Clinical Ethics. 19, 2018. 19: p. 58-61.

  31. Ashraf, B., Saaiq M, Zaman KU, Qualitative study of Nocebo Phenomenon (NP) involved in doctor-patient communication. Int J Health Policy Manag. 2014. 3 (1): p. 23-7.

  32. Hauser, W., E. Hansen, and P. Enck, Nocebo phenomena in medicine: their relevance in everyday clinical practice. Dtsch Arztebl Int. 2012. 109 (26): p. 459-65.

  33. Benson, H., The nocebo effect: history and physiology. Prev Med. 1997. 26 (5 Pt 1): p. 612-5.

  34. Vinker, S., V. Eliyahu, and J. Yaphe, The effect of drug information leaflets on patient behavior. Isr Med Assoc J. 2007. 9 (5): p. 383-6.

  35. Der Spiegel, (magazine), Arzneimittelrisiken: Verstehen Sie den Beipackzettel? (in German) 28/2017, 2017.

  36. Planes, S., C. Villier, and M. Mallaret, The nocebo effect of drugs. Pharmacol Res Perspect. 2016. 4 (2): p. e00208.

  37. Barsky AJ1, Saintfort R, Rogers MP, et al. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002. 287 (5): p. 622-7.

  38. Loewy, E.H., Spinger R. The Ethics of Terminal Care Orchestrating the End of Life. Kluwer Academic Publishers. New York Boston, Dordrecht, London, Moscow.

  39. Bok, S., The ethics of giving placebos. Sci Am. 1974. 231 (5): p. 17-23.

  40. Brody, H., The lie that heals: the ethics of giving placebos. Ann Intern Med. 1982. 97 (1): p. 112-8.

  41. Kaptchuk TJ, Kelley FE, Sanchez JM et al: PLoS One 2010, 5:e15591., Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010, 5:e15591., 2010.

  42. Castaneda R, Lifshutz H, Galanter M, et al Empirical assessment of the self-medication hypothesis among dually diagnosed inpatients. Compr Psychiatry. 1994. 35 (3): p. 180-4.

  43. Avins AL, Cherkin DC, Sherman KJ ,et al Should we reconsider the routine use of placebo controls in clinical research? Avins et al. Trials 2012, 13:44 http://www.trialsjournal.com/content/13/1/44, 2012.

  44. World Medical association, WMA DECLARATION OF HELSINKI – ETHICAL PRINCIPLES FOR MEDICAL RESEARCH INVOLVING HUMAN SUBJECTS. wma.net. 2017.

  45. Kaptchuk, T.J. Acupuncture: theory, efficacy, and practice. Ann Intern Med. 2002. 136 (5): p. 374-83.

  46. Pan, C.X.,Morrison RS, Ness J, et al. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage. 2000. 20 (5): p. 374-87.

  47. Pan, S.Y., , Gao SH, Zhou SF,et al. New perspectives on complementary and alternative medicine: an overview and alternative therapy. Altern Ther Health Med. 2012. 18 (4): p. 20-36.

  48. De la Cruz, M.,Hui D , Parsons HA, et al Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer. 2010. 116 (3): p. 766-74.






>Journals >Revista Mexicana de Neurociencia >Year 2018, Issue 4
 

· Journal Index 
· Links 






       
Copyright 2019